COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Déclaration de transactions sur actions propres
08/04/2025
Déclaration de transactions sur actions propres Paris, France (8 avril 2025, 18h15) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 3 avril 2025 au 7 [...]
Ipsen publishes its 2024 Universal Registration Document
08/04/2025
Ipsen publishes its 2024 Universal Registration Document PARIS, FRANCE, 8 April 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the filing of its 2024 Universal Registration Document with the French Autorité [...]
Ipsen publie son Document d’enregistrement universel 2024
08/04/2025
Ipsen publie son Document d’enregistrement universel 2024 PARIS, FRANCE, 8 avril 2025 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce aujourd’hui que son Document d’enregistrement universel 2024 a été déposé le 7 avril [...]
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
08/04/2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 8 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the [...]
Neurona Therapeutics Presents Positive Clinical Data Update from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy at American Academy of Neurology Annual Meeting
08/04/2025
– EFFICACY : 92% median reduction in disabling seizures during 7-12-month efficacy endpoint period, and 80% (4/5) of patients responding with >75% seizure reduction in Cohort 1. – DURABILITY : All responders (4/4) in [...]
Cerevance Presents Positive Results from Phase 1 Study of CVN293 at American Academy of Neurology 2025 Annual Meeting
08/04/2025
CVN293 was generally well-tolerated in healthy volunteers with evidence of robust brain penetration, supporting utility of KCNK13 inhibitors for neurodegenerative diseases characterized by neuroinflammation Additional [...]
Better Choice Company Revises Payment Date for Stock Dividend of 0.35 per Share for Each Share Held for Stockholders of Record as of April 17, 2025
08/04/2025
TAMPA, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced on April 7, 2025 that its Board of [...]
Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order
08/04/2025
CHICAGO, April 08, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]
iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer
08/04/2025
NASHUA, N.H., April 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered [...]
AscellaHealth Showcases Rare Disease Expertise and Comprehensive Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025
08/04/2025
BERWYN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, proudly announces its role as a Silver Sponsor at the [...]
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
08/04/2025
LONDON and PHOENIX, April 08, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of [...]
AMPS Raises the Bar on RBP with PriceDynamix: Delivering Elevated Member Advocacy, Smarter Savings, and Greater Accountability
08/04/2025
PHOENIX, April 08, 2025 (GLOBE NEWSWIRE) -- The healthcare industry has outgrown the outdated and rigid model of Reference-Based Pricing. AMPS, a leader in healthcare cost savings and advocacy, is raising the bar with [...]
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/04/2025
MIAMI, April 08, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of InspireMD’s [...]
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer
08/04/2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers, today announced the appointment of [...]
Privia Health to Report First Quarter 2025 Results on Thursday, May 8
08/04/2025
ARLINGTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2025 before market open on [...]
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building
08/04/2025
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, and The Broken Brown Egg, a nonprofit supporting BIPOC individuals and couples [...]
CORRECTION: ProDentim
08/04/2025
2025 buyers reveal everything: From fresher breath and gum healing to the surprising downsides no one talks about. In a release issued under the same headline on April 1, 2025 by ProDentim, please note that the headline [...]
SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML
08/04/2025
- 8.9 Months Median Overall Survival (mOS) in Patients with AML-Myelodysplasia-Related Changes (AML-MRC) and 8.8 mOS in All Relapsed or Refractory to Venetoclax-Based Regimens Patients; Surpassing Historical Benchmark [...]
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
08/04/2025
Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq [...]

Pages